Cell Therapy Targets for Autism Spectrum Disorders: Hopes, Challenges and Future Directions Publisher Pubmed



Larijani B¹ ; Foroughi Heravani N² ; Alavimoghadam S² ; Goodarzi P³ ; Rezaeitavirani M⁴ ; Payab M⁵ ; Gholami M⁶ ; Razi F⁸ ; Arjmand B^{2, 9} Show Affiliations
Source: Advances in Experimental Medicine and Biology Published:2021

Abstract

Autism spectrum disorders as a group of pediatric neurodevelopmental diseases is a crucial part of the worldwide disabilities which have influence in communication skills, social interactions, and ability to understand the concepts. The precise pathophysiology of autism spectrum disorders due to the abundance of involved mechanisms is unknown. Some of these involved mechanisms are related to genetic factors, chronic neuro inflammation, mitochondrial dysfunction, oxidative stress, immune dysregulation, hormonal imbalance, and environmental factors. Current main treatments for autisms are behavioral, nutritional and medical therapies, however there is not definitive treatment approach. Therein, more novel therapies are still required to improve the symptoms. Several preclinical and clinical evidence were shown that stem cell therapy is a potential treatment option for autism spectrum disorders individuals. Considering the significant factors which can affect the outcome of stem cell therapeutic effects including stem cell types, route and dosage of administration, and mechanism of activity along with selecting best animal models can be very important in performing clinical trials. © 2020, Springer Nature Switzerland AG.